Stay updated on Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe study page now indicates recruitment is closed and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). There is a minor formatting update to the Intervention/Treatment heading and the revision tag at the bottom has been updated from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check14 days agoChange DetectedThe page's revision tag was updated to v3.5.5, signaling a minor metadata update. No study content, eligibility criteria, or results were changed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a refreshed version of the page rather than changes to the study details.SummaryDifference0.1%

- Check57 days agoChange DetectedClinicalTrials.gov updated the page’s display revision label from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.5.2 added, replacing the previous v3.5.0.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page.SummaryDifference0.1%

Stay in the know with updates to Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.